Novel Gene Therapy Solution for Abnormal Fuel Metabolism and Diminished Contractile Function of the Diabetic Heart
There are currently no specific approaches available for correcting abnormal fuel flux and improving contractile function of the diabetic heart. Utilizing this novel gene therapy approach, cardiac function could potentially be returned to normal in spite of persistent diabetes in the patient.
UCSD researchers have discovered a novel gene therapy to correct the abnormal fuel flux in diabetic cardiac myocytes and significantly increase the contractile performance of the heart.
State Of Development Work in animal models has demonstrated feasibility of the approach, and expression of the transgene in human cardiac muscle cells has been accomplished. Intellectual Property Info This technology is available for licensing. Tech ID/UC Case 24104/2014-256-0 Related Cases 2014-256-0
美國
